 |
|
|
| |
Use of Telaprevir Plus Peg Interferon/Ribavirin for Null Responders Post OLT With Advanced Fibrosis/Cholestatic Hepatitis C
|
| |
| |
Reported by jules Levin
EASL 2012
Kwo PJ1,3, Ghabril M1,3, Lacerda M1,3, Vinayek R1,3, Tector AJ2,3, Fridell J2,3, Vianna R 2,3.
1Medicine, Indiana University School of Medicine, 2Transplant Surgery, Indiana School of Medicine, 3Indiana University Health, Indianapolis, IN USA
|
| |
|
|
|
|
|
